Subira Pharmaceuticals Private Limited, a active private limited company, was established on 08 October 2013 in Mumbai, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the manufacturing sector, it holds CIN: U24233MH2013PTC328984. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Vishal Khanna (Director), Kavita Khanna (Director). It holds ₹5.00 M open charges and ₹2.21 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at A-408, Fairlink Centre Chs Ltd. Off. Link Road, Andheri West, Mumbai, Maharashtra, 400053.
U24233MH2013PTC328984
328984
08 October 2013
₹0.50 M
₹0.10 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Subira Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vishal Khanna | Director | 08 Oct 2013 | Current |
| Kavita Khanna | Director | 08 Oct 2013 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Subira Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 17.6% increase. The company also saw a substantial fall in profitability, with a 24.26% decrease in profit. The company's net worth Soared by an impressive increase of 21.12%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Subira Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹5,000,000.00
₹22,073,390.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Jan 2025 | Hdfc Bank Limited | ₹5.00 M | Open |
| 04 May 2022 | Hdfc Bank Limited | ₹2.50 M | Satisfied |
| 01 Dec 2020 | Others | ₹1.96 Cr | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Subira Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Subira Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Subira Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity A charge with Hdfc Bank Limited amounted to Rs. 5.00 M with Charge ID 101041149 was registered on 30 Jan 2025. was completed.
The activity A charge registered on 04 May 2022 via Charge ID 100571724 with Hdfc Bank Limited was fully satisfied on 22 Jan 2025. was completed.
Subira Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Subira Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was recorded as a recent event.
A charge with Hdfc Bank Limited amounted to Rs. 2.50 M with Charge ID 100571724 was registered on 04 May 2022. was recorded as a recent event.
A charge registered on 01 Dec 2020 via Charge ID 100401055 with Others was fully satisfied on 03 Feb 2022. was recorded as a recent event.
The CIN of Subira Pharmaceuticals Private Limited is U24233MH2013PTC328984.
Subira Pharmaceuticals Private Limited is headquartered at A-408, Fairlink Centre Chs Ltd. Off. Link Road, Andheri West, Mumbai, Maharashtra, 400053.
Subira Pharmaceuticals Private Limited was incorporated on 08 October 2013.
The current directors of Subira Pharmaceuticals Private Limited are
The primary industry of Subira Pharmaceuticals Private Limited is Manufacturing.
Subira Pharmaceuticals Private Limited is unlisted.
The authorized capital of Subira Pharmaceuticals Private Limited is ₹0.50 M, and the paid-up capital is ₹0.10 M.
The compliance status of Subira Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX